LU85511A1 - Nouvelles compositions injectables - Google Patents

Nouvelles compositions injectables Download PDF

Info

Publication number
LU85511A1
LU85511A1 LU85511A LU85511A LU85511A1 LU 85511 A1 LU85511 A1 LU 85511A1 LU 85511 A LU85511 A LU 85511A LU 85511 A LU85511 A LU 85511A LU 85511 A1 LU85511 A1 LU 85511A1
Authority
LU
Luxembourg
Prior art keywords
weight
particles
microns
metronidazole
suspension according
Prior art date
Application number
LU85511A
Other languages
English (en)
French (fr)
Inventor
Andrew Lewis
Robert Paul Haslam
John Howard Bell
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of LU85511A1 publication Critical patent/LU85511A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LU85511A 1983-08-19 1984-08-17 Nouvelles compositions injectables LU85511A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8322364 1983-08-19
GB838322364A GB8322364D0 (en) 1983-08-19 1983-08-19 Compositions of matter

Publications (1)

Publication Number Publication Date
LU85511A1 true LU85511A1 (fr) 1985-04-24

Family

ID=10547557

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85511A LU85511A1 (fr) 1983-08-19 1984-08-17 Nouvelles compositions injectables

Country Status (17)

Country Link
JP (1) JPS6067468A (da)
AU (1) AU577055B2 (da)
BE (1) BE900381A (da)
CA (1) CA1214727A (da)
CH (1) CH662812A5 (da)
DE (1) DE3430354A1 (da)
DK (1) DK165817C (da)
FR (1) FR2560043B1 (da)
GB (2) GB8322364D0 (da)
HU (1) HU192990B (da)
IL (1) IL72714A (da)
IT (1) IT1213208B (da)
LU (1) LU85511A1 (da)
NL (1) NL8402510A (da)
NZ (1) NZ209270A (da)
SE (1) SE460095B (da)
ZA (1) ZA846431B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
US7849856B2 (en) 2001-06-25 2010-12-14 3M Innovative Properties Company Respirator valve

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB213928A (en) * 1923-04-06 1925-07-02 Deutsche Werke Ag Improvements in or relating to compensated induction motors for single or polyphase alternating current
US3457348A (en) * 1966-06-27 1969-07-22 American Cyanamid Co Stable syringeable suspensions of parenteral drugs in complex floc form
GB1430411A (en) * 1973-04-05 1976-03-31 May & Baker Ltd Method and compositions for combating swine dysentery
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
GB2000025A (en) * 1977-05-14 1979-01-04 Pfizer Ltd Nitroimidazole formulations
DE2932691A1 (de) * 1979-08-11 1981-04-09 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoeherer freisetzung der wirkstoffe

Also Published As

Publication number Publication date
DK397084D0 (da) 1984-08-17
DK397084A (da) 1985-02-20
JPS6067468A (ja) 1985-04-17
BE900381A (fr) 1985-02-18
DK165817B (da) 1993-01-25
FR2560043B1 (fr) 1988-08-05
GB8420959D0 (en) 1984-09-19
GB2145088B (en) 1986-10-08
SE8404130L (sv) 1985-02-20
IT8422323A0 (it) 1984-08-13
FR2560043A1 (fr) 1985-08-30
ZA846431B (en) 1985-03-27
CA1214727A (en) 1986-12-02
SE8404130D0 (sv) 1984-08-17
GB8322364D0 (en) 1983-09-21
DK165817C (da) 1993-06-21
IT1213208B (it) 1989-12-14
AU3202284A (en) 1985-02-21
NL8402510A (nl) 1985-03-18
AU577055B2 (en) 1988-09-15
NZ209270A (en) 1988-02-29
DE3430354A1 (de) 1985-03-07
HUT35650A (en) 1985-07-29
HU192990B (en) 1987-08-28
IL72714A (en) 1988-09-30
SE460095B (sv) 1989-09-11
CH662812A5 (fr) 1987-10-30
GB2145088A (en) 1985-03-20

Similar Documents

Publication Publication Date Title
RU2028142C1 (ru) Фармацевтический раствор
FR2761265A1 (fr) Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
CH695185A5 (fr) Compositions pharmaceutiques injectables contenant de la piperacilline et du tazobactame et procede pour leur production.
FR2588189A1 (fr) Composition pharmaceutique de type a transition de phase liquide-gel
CA2052950A1 (en) Aqueous ophthalmic microemulsions of tepoxalin
US20130052241A1 (en) Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
FR2458285A1 (fr) Preparation pharmaceutique transdermique au dinitrate d'isosorbide
TW201622705A (zh) 包含度他雄胺之用於自發性乳化藥物傳輸系統的組合物
EP4429634A1 (fr) Solution pharmaceutique d'hydrocortisone pour dispositif d'injection
WO2011036357A2 (fr) Formulation liquide, stable, prete a l'emploi de ketoprofene
FR2753376A1 (fr) Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
BE1000442A4 (fr) Composition therapeutique seche a base de sel de diclofenac.
LU85511A1 (fr) Nouvelles compositions injectables
JP3917820B2 (ja) オザグレルナトリウム含有注射液およびその安定化方法
FR2756736A1 (fr) Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
JPH06247853A (ja) 安定なビタミンａ類及びビタミンｅ類可溶化点眼剤
BE1004051A4 (fr) Solution injectable et procede pour la preparer.
JP2013537554A (ja) 改良された臓器移植の保存および許容のための組成物および方法
JP6598158B2 (ja) パロノセトロンを含有する安定な注射用液剤の製造方法
KR102066108B1 (ko) 페닐링을 가지는 2종 화합물을 포함하는 화장료 조성물
JP6189437B2 (ja) 注射用抗生物質製剤およびその使用方法
EP3328356A1 (de) Konzentrat enthaltend alprostadil
EP0433140B1 (fr) Nouvelle préparation pharmaceutique anti-allergique à action prolongée
WO2008099068A2 (fr) Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage
Anum et al. Development and characterization of ceftriaxone in-situ gel-forming biodegradable parenteral depot system